This paper is confusing. They say the levels in PDD are higher but in the figure they are lower. Given the large overlap in values between PDD and controls, this antibody cannot be used as a biomarker, at least not on its own. https://t.co/lVvsCaz9T2
Could "naturally occurring antibody against α-Syn" be a potential biomarker for #Parkinsons dementia? https://t.co/IsbLKngdiU https://t.co/MQ0pUKX5W1
New Research: Differential Circulating Levels of Naturally Occurring Antibody to α-Synuclein in Parkinson’s Disease Dementia, Alzheimer’s Disease, and Vascular Dementia: Background: Aggregation of alpha-synuclein (α-Syn) is… https://t.co/wrGWB3hAZZ #ageing